Cargando…

Type 1 Diabetes Risk Phenotypes Using Cluster Analysis

BACKGROUND: Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal clinically meaningful clusters in the at-risk population and allow for non-linear relationships between predictors are lacking. We aimed to identify and characterize clusters of is...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Lu, Ferrat, Lauric A., Oram, Richard A., Parikh, Hemang M., Steck, Andrea K., Krischer, Jeffrey, Redondo, Maria J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593014/ https://www.ncbi.nlm.nih.gov/pubmed/37873281 http://dx.doi.org/10.1101/2023.10.10.23296375

Ejemplares similares

Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults
por: Lynam, Anita L., et al.
Publicado: (2020)

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
por: Redondo, Maria J., et al.
Publicado: (2018)

Classifying dynamic transitions in high dimensional neural mass models: A random forest approach
por: Ferrat, Lauric A., et al.
Publicado: (2018)

ISLET: individual-specific reference panel recovery improves cell-type-specific inference
por: Feng, Hao, et al.
Publicado: (2023)

Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
por: Mattila, Markus, et al.
Publicado: (2019)

TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
por: Redondo, Maria J., et al.
Publicado: (2018)

Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
por: Bonifacio, Ezio, et al.
Publicado: (2018)

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials
por: Kinney, Mara, et al.
Publicado: (2023)

Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus
por: Parikh, Hemang, et al.
Publicado: (2009)

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2014)

Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2015)

A quantitative measure of treatment response in recent‐onset type 1 diabetes
por: Bundy, Brian N., et al.
Publicado: (2020)

Risk of Islet and Celiac Autoimmunity in Cotwins of Probands With Type 1 Diabetes
por: Triolo, Taylor M, et al.
Publicado: (2020)

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients
por: Sosenko, Jay M., et al.
Publicado: (2013)

Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families
por: Hippich, Markus, et al.
Publicado: (2019)

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes
por: Sosenko, Jay M., et al.
Publicado: (2014)

The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
por: Sosenko, Jay M., et al.
Publicado: (2012)

Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection
por: Lin, Jake, et al.
Publicado: (2023)

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis
por: Xu, Ping, et al.
Publicado: (2012)

Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
por: Törn, Carina, et al.
Publicado: (2022)

Utility of genetic risk scores in type 1 diabetes
por: Luckett, Amber M., et al.
Publicado: (2023)

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)

Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes
por: Steck, Andrea K., et al.
Publicado: (2014)

Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study
por: Beyerlein, Andreas, et al.
Publicado: (2019)

Stepwise or Linear Decrease in Penetrance of Type 1 Diabetes With Lower-Risk HLA Genotypes Over the Past 40 Years
por: Steck, Andrea K., et al.
Publicado: (2011)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2008)

Dietary Patterns, Socioeconomic Status, and Risk of Type 2 Diabetes in the Sister Study
por: Crawford, Brittany, et al.
Publicado: (2022)

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
por: Felton, Jamie L., et al.
Publicado: (2023)

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study
por: Sosenko, Jay M., et al.
Publicado: (2011)

SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens
por: Krischer, Jeffrey P., et al.
Publicado: (2023)

Precision medicine in type 1 diabetes
por: Carr, Alice L. J., et al.
Publicado: (2022)

The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes
por: Bingley, Polly J., et al.
Publicado: (2015)

Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2016)

Type 2 Diabetes Clusters Indicate Diabetes Duration Key in Fracture Risk
por: Ghatan, Sam, et al.
Publicado: (2021)

Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study
por: Li, Qian, et al.
Publicado: (2020)

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013)

Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785–1787
por: Sosenko, Jay M., et al.
Publicado: (2018)

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2013)

Evidence of Stage- and Age-Related Heterogeneity of Non-HLA SNPs and Risk of Islet Autoimmunity and Type 1 Diabetes: The Diabetes Autoimmunity Study in the Young
por: Frederiksen, Brittni N., et al.
Publicado: (2013)

A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns
por: Lin, Ying, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bonesefivk87j8iq4jj8c3e69m